By Fineline Cube 
China-based Nanjing Perlove Medical Equipment Co., Ltd., a specialist in medical imaging and surgical robotics, has submitted an IPO application to the Hong Kong Stock Exchange. Details regarding the offering size, unit price, and timeline remain undisclosed.
Company Overview and Technology Portfolio
Since its founding in 2003, Perlove has developed a comprehensive portfolio of over 100 medical imaging devices. The company’s proprietary technologies include X-ray tube components, high-voltage generators, and AI-driven 3D imaging systems. Its flagship product, an integrated orthopedic surgical robot paired with a mobile 3D C-arm, received China’s Class III medical device approval in June 2022, the highest regulatory classification in the country.
Market Presence and Expansion
As of 2024, Perlove serves over 1,200 hospitals and medical institutions in China and collaborates with more than 200 overseas distributors across emerging markets. The IPO application underscores the company’s strategic focus on expanding its global reach and enhancing its market position in the medical imaging and surgical robotics sector.-Fineline Info & Tech